Dear colleagues, this week I would like to explore some issues that are apparently unconnected but which find a single true starting point.
Many of you will have read about the alleged bribes to Senator Cursi, necessary to increase the cost of the drugs of a well-known German company, also noting how from the interrogations relating to this investigation most of them have come to know an unknown pharmaceutical world, in which the health needs of patients are not taken into consideration in the least, while the aspects of earnings and profit are the only real concern of the managers of this sector.
The construction of a comparison system with libraries (if the investigations in this sector were to be expanded, surely there would be some good ones) are the tip of the hidden iceberg. How many pharmaceutical companies would operate as described in the Corriere della Sera article of March 26, 2010? Here is the system: “Some internal managers or regional representatives of scientific representatives explain the mystery to the prosecutors, recounting how those who did not reach the pre-set budgets were summoned and denigrated in public: "The commercial management asked us to enter into a sort of agreement in which the doctor's remuneration was based on the number of patients that the doctor procured" in the growth hormone market, contested between a few products and almost all the same, where it was therefore crucial to "retain" as many of the 650 specialists in the field as possible".
In short, without being Pico della Mirandola it doesn't take long to understand that in many companies the so-called job cuts are nothing more than a method of personnel selection. Anyone who corresponds to certain marketing methods and silences the system stays. The others out.
Even the creation of mature product lines in companies what are they for? To create new professional opportunities where to insert new isfs in a now mature and profitable market or what? Or to ghettoize those who do not correspond to certain characteristics? Or, even worse, to prepare a package of workers to send them to a place of no return?
And what to say about the triumphal utterances of the pharmaceutical elite who in an interview present in the Aifa press review at the web address http://www.ecostampa.com/Servizi/RasClienti/imgrsnew.asp?numart=QOI3D&annart=2010&numpag=1&tipcod=0&tipimm=1&defimm=0&tipnav=1&isjpg=S&small=N&usekey=B1Q4U2DE19V29&video=0 still paint a world in which the drug manufacturers seem to be benefactors of humanity, without blemish and without any fault.
But where do we live?
Do you really think we are all idiots?
And what is continuing to happen in the sector with continuous staff dismissals, with an exponential increase in conflict between companies and workers which increasingly lead to legal disputes (increasingly on the increase) and the continuous scandals that appear every day in the newspapers and in the media, what do they say?
I'll leave everyone with their own considerations, but let's avoid false respectability and then dear colleagues, enough with the whining and let's begin to act as many are already individually doing.
Umberto Alderis
